Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2005
11/10/2005US20050249669 Quadruplex stabilizer
11/10/2005US20050249668 Nir-fluorescent cyanine dyes, their synthesis and biological use
11/10/2005US20050249666 Establishment of human cancer cell lines with metastatic potential using NOD/SCID
11/10/2005US20050249664 Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis
11/10/2005CA2564737A1 Contrast agents for myocardial perfusion imaging
11/10/2005CA2564557A1 Method and apparatus for accumulating hyperpolarized xenon
11/10/2005CA2564525A1 Ion channel
11/10/2005CA2564231A1 Method of constructing animal model suffering from left ventricular diastolic disorder for examining heart failure and method of examining remedy for heart failure caused by left ventricular diastolic failure with the use of the animal model
11/10/2005CA2562527A1 Polymer conjugate releasable under mild thiolytic conditions
11/09/2005EP1593395A2 Gas filled microspheres as magnetic resonance imaging contrast agents
11/09/2005EP1593091A2 High contrast optoacoustical imaging using nanoparticles
11/09/2005EP1592456A1 Contrast enhanced x-ray phase imaging
11/09/2005EP1438318B1 Tissue specific fluorescent chelates
11/09/2005EP1421155A4 Colloidal nanocrystals with high photoluminescence quantum yields and methods of preparing the same
11/09/2005EP0751992B1 Vascular endothelial growth factor 2
11/09/2005CN1694731A Method and apparatus for producing contrast agents for magnetic resonance imaging
11/09/2005CN1694730A Method and apparatus for producing contrast agents for magnetic resonance imaging
11/09/2005CN1694729A Method and arrangement for producing contrast agent for magnetic resonance imaging
11/09/2005CN1692947A Gadolinium-doped nanometer composite material, and its prepn. method
11/08/2005US6963769 administering a contrast agent to perform chemical exchange dependent saturation transfer magnetic resonance imaging analysis
11/08/2005US6962710 Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/08/2005US6962702 Diagnosis of tissue damage, cancer
11/08/2005US6962690 A tetraazamacrocyclic compounds, chelated with lanthanide, terbium, europium and dysprosium; visual contrast enhancement agents or diagnostic agents
11/08/2005US6962689 Suited for treating vascular lesions via catheter delivery of formulation; for treating aneurysms, arteriovenous malformations (AVMs) at high flow fistulas and embolizing blood vessels
11/08/2005US6962687 Method and means for detecting inflammatory processes
11/08/2005US6962686 Cell-specific gene delivery vehicles
11/08/2005US6962071 Method for improved measurement of local physical parameters in a fluid-filled cavity
11/03/2005WO2005102456A1 Composition and method for cancer treatment
11/03/2005WO2005102396A2 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
11/03/2005WO2005101993A2 Metal-containing nanolayered composites, and applications thereof
11/03/2005WO2005025511A3 Potassium channel mediated delivery of agents through the blood-brain barrier
11/03/2005WO2004108070A3 Releasable polymeric conjugates based on aliphatic biodegradable linkers
11/03/2005WO2004080285A3 Amyloid plaque as a target for therapeutics that function by blocking or disrupting chitin synthesis or activity
11/03/2005US20050245445 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
11/03/2005US20050245442 Androgens conjugated with mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit synergistic action together with a cytoskeleton-acting drug; prostate cancer
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005US20050244808 Subjecting a zebrafish larva to laser irradiation or exposing a zebrafish to water containing sodium hydroxide; the fish are used for identifing anti-thrombotic agents and for identifying genes associated with all aspects of thrombus formation
11/03/2005US20050244807 Two-photon absorption heteroaromatic chromophores and compositions thereof
11/03/2005US20050244408 gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies; colorectal or breast cancer tumor
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244338 Ultrasonic imaging system utilizing a long-persistence contrast agent
11/03/2005US20050244337 Medical and biological devices with magnetism
11/03/2005US20050244336 Diagnostic method for atherosclerosis
11/03/2005US20050244335 Methods and compositions related to increasing antitumor activity of chemotherapeutic agents
11/03/2005US20050244332 Contrast agents for myocardial perfusion imaging
11/03/2005US20050241652 Surface topography method for determining effects of a botulinum toxin upon a muscle and for comparing botulinum toxins
11/03/2005DE102004017705A1 Ferromagnetische Kohlenstoff-Nanoröhren, die Biomoleküle tragen, Verfahren zu deren Herstellung und deren Verwendung in Diagnose und Therapie Ferromagnetic carbon nanotubes carrying biomolecules, processes for their preparation and their use in diagnosis and therapy
11/03/2005CA2563619A1 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
11/03/2005CA2561073A1 Composition and method for cancer treatment
11/03/2005CA2551643A1 Metal-containing nanolayered composites, and applications thereof
11/02/2005EP1591142A1 Apparatus and method for recording and rendering homeopathic information
11/02/2005EP1590647A2 Remote nmr/mri detection of laser polarized gases
11/02/2005EP1590365A2 Mycobacterial diagnostics
11/02/2005EP1590007A1 Improved radiometal complex compositions
11/02/2005EP1590006A2 Ultrasound contrast agents and process for the preparation thereof
11/02/2005EP1590004A2 Improved thickened beverages for dysphagia
11/02/2005EP1590003A1 Method and apparatus for determining effectiveness of sunscreens and other skin preparations in shielding human skin from uva radiation
11/02/2005EP1450859A4 Methods and compositions for the diagnosis of asthma
11/02/2005EP1430071A4 Secreted and cell surface genes expressed in benign and malignant colorectal tumors
11/02/2005EP1416965A4 Assay method for alzheimer's disease
11/02/2005EP1251780A4 LUMINESCENT i IN VIVO /i GLUCOSE MEASUREMENT
11/02/2005EP1246826B1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
11/02/2005CN1691964A Epitope sequences
11/01/2005US6961607 Method for assessing myocardial angiogenesis
10/2005
10/27/2005WO2005101044A1 A solid state nmr involving relaxor with rapidly rotating molecular section and protective cage
10/27/2005WO2005100848A1 Luminaires
10/27/2005WO2005100612A2 Bacteriophage imaging of inflammation
10/27/2005WO2005100577A1 Method for gene delivery to neuronal cells
10/27/2005WO2005100300A1 5-aminolevulinic acid salt, process for producing the same and use thereof
10/27/2005WO2005099775A2 Labeled anwexin for predicting the response to a therapeutic regimen
10/27/2005WO2005099774A2 Diagnosis and treatment of myeloid and lymphoid cell cancers
10/27/2005WO2005099773A1 Use of erythropoietin for treatment of cancer
10/27/2005WO2005099717A1 Macular edema patient selection method and treatment with eye implant comprising a steroid
10/27/2005WO2005067982A3 Methods for imaging the lymphatic system using dendrimer-based contrast agents
10/27/2005WO2004110255A3 Antineoplastic agents targeted via glut transporters
10/27/2005US20050239905 Smooth muscle peristole inhibitor
10/27/2005US20050239763 Non-GMO metal amino acid chelates and non-GMO metal amino acid chelate-containing compositions
10/27/2005US20050239147 Exposing a test sample from an animal, e.g., bovine, to a population of microorganisms, especially killed Mycobacterium avium subsp. paratuberculosis, and determining if the test sample contains an antibody that binds to the microorganism, preferably to the surface of the microorganism
10/27/2005US20050238619 Method for the delivery of sustained release agents
10/27/2005US20050238586 Preparation of further diagnostic agents
10/27/2005US20050238585 Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media
10/27/2005US20050238584 Sterically stabilized liposomes with hydrophilic polymers on surface; computed tomography
10/27/2005US20050238583 Contrast agent specifically suitable for X-ray computed tomography
10/27/2005US20050238582 Administering a conjugate of a a cell and a light-generating moiety; and measuring photon emission through an opaque tissue of said mammalian subject from the light-generating moiety; used for tracking the progression of infection
10/27/2005US20050238581 Dynamic hepatic recycling glucose tolerance test
10/27/2005US20050238577 Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling
10/27/2005US20050235693 Method and apparatus for accumulating hyperpolarized xenon
10/27/2005CA2562699A1 Systems and methods for improving image-guided tissue ablation
10/27/2005CA2562170A1 5-aminolevulinic acid salt, process for producing the same and use thereof
10/27/2005CA2561680A1 Macular edema patient selection method and treatment with eye implant comprising a steroid
10/27/2005CA2561494A1 Diagnosis and treatment of myeloid and lymphoid cell cancers
10/26/2005EP1589036A1 Amides of hyaluronic acid and the derivatives thereof
10/26/2005EP1588699A2 Container with multi-phase composition for use in diagnostic and therapeutic applications
10/26/2005EP1588167A2 Sperm specific lysozyme-like proteins
10/26/2005EP1587944A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
10/26/2005EP1587548A1 Echogen microparticles essentially used as a contrast agent for ultrasound exploration and/or as emboli for ultrasound detection
10/26/2005EP1587547A2 Amyloid-binding, metal-chelating agents
10/26/2005EP1587510A1 Method for treating ischemic stroke with melatonin
10/26/2005EP1390078A4 Ct scanner for imaging a preselected portion of a patient
10/26/2005EP0825879B1 Process for the depyrogenation of injectable pharmaceutical solutions
1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 354